Study title: EC-CX-012. A phase II clinical trial of cardioprotection with cardioxane (ICRF-187) in pediatric patients with Osteosarcoma. 30th November 1999.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Cardiovascular Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: DEXRAZONANE | |||||
ATC code: V03AF02 | |||||
Document link: Cardioxane EC-CX-012.xls | |||||
Document date: 2011-09-16 | |||||
Study number: EC-CX-012 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |